The EuroEspes International Centre for Neuroscience and Genomic Medicine bases its activity on cutting-edge Personalised Medicine using all the diagnostic and therapeutic resources provided by structural and functional genomics, epigenetics, transcriptomics, proteomics, and metabolomics.
EuroEspes is an International Centre of Reference in Genomic Medicine, dedicated above all to diseases of the nervous system and other prevalent diseases (cardiovascular diseases, cancer, metabolic disorders, and any genetic-based pathology).
The three major pathologies that account for 80% of morbidity and mortality in developed countries are cardiovascular diseases ( 25-35%), cancer (20-30%) and brain disorders (10-20%). 80-90% of these prevalent diseases have a multifactorial pathogenesis in which genomic factors and environmental factors converge. Although these diseases can occur at any age, in more than 70% of cases they are age-dependent pathologies, which accumulate with age, increasing their prevalence in adulthood and old age. Consequently, they are diseases that develop throughout life and, therefore, are predictable with the appropriate predictive procedures, and susceptible to prevention, since when they appear they have already been undermining our body for decades.
One of the priorities of the International Centre for Neuroscience and Genomic Medicine is the implementation of Prevention Plans for prevalent diseases to identify them in pre-symptomatic or early stages and to be able to intervene prophylactically so that they do not manifest themselves, delay their onset or can be intervened therapeutically in an effective way with personalised protocols of individual pharmacogenetics.